TY - JOUR
T1 - Thermal stability of siRNA modulates aptamerconjugated siRNA inhibition
AU - Berezhnoy, Alexey
AU - Brenneman, Randall
AU - Bajgelman, Marcio
AU - Seales, Dawn
AU - Gilboa, Eli
N1 - Funding Information:
The authors declare no commercial affiliation, consulting arrangements, stock, equity or any other potential financial conflict of interest. Funding was provided by a bequest from the Dodson Estate andthe Sylvester Comprehensive Cancer Center (Miller School of Medicine, University of Miami), and a grant (KG090348) from the Susan G. Komen for the Cure of Breast Cancer Foundation.
PY - 2012
Y1 - 2012
N2 - Oligonucleotide aptamer-mediated in vivo cell targeting of small interfering RNAs (siRNAs) is emerging as a useful approach to enhance the efficacy and reduce the adverse effects resulting from siRNA-mediated genetic interference. A current main impediment in aptamer-mediated siRNA targeting is that the activity of the siRNA is often compromised when conjugated to an aptamer, often requiring labor intensive and time consuming design and testing of multiple configurations to identify a conjugate in which the siRNA activity has not been significantly reduced. Here, we show that the thermal stability of the siRNA is an important parameter of siRNA activity in its conjugated form, and that siRNAs with lower melting temperature (Tm) are not or are minimally affected when conjugated to the 3' end of 2'F-pyrimidine-modified aptamers. In addition, the configuration of the aptamer-siRNA conjugate retains activity comparable with the free siRNA duplex when the passenger strand is co-transcribed with the aptamer and 3' overhangs on the passenger strand are removed. The approach described in this paper significantly reduces the time and effort necessary to screening siRNA sequences that retain biological activity upon aptamer conjugation, facilitating the process of identifying candidate aptamer-siRNA conjugates suitable for in vivo testing.
AB - Oligonucleotide aptamer-mediated in vivo cell targeting of small interfering RNAs (siRNAs) is emerging as a useful approach to enhance the efficacy and reduce the adverse effects resulting from siRNA-mediated genetic interference. A current main impediment in aptamer-mediated siRNA targeting is that the activity of the siRNA is often compromised when conjugated to an aptamer, often requiring labor intensive and time consuming design and testing of multiple configurations to identify a conjugate in which the siRNA activity has not been significantly reduced. Here, we show that the thermal stability of the siRNA is an important parameter of siRNA activity in its conjugated form, and that siRNAs with lower melting temperature (Tm) are not or are minimally affected when conjugated to the 3' end of 2'F-pyrimidine-modified aptamers. In addition, the configuration of the aptamer-siRNA conjugate retains activity comparable with the free siRNA duplex when the passenger strand is co-transcribed with the aptamer and 3' overhangs on the passenger strand are removed. The approach described in this paper significantly reduces the time and effort necessary to screening siRNA sequences that retain biological activity upon aptamer conjugation, facilitating the process of identifying candidate aptamer-siRNA conjugates suitable for in vivo testing.
KW - Aptamer
KW - Aptamer targeting
KW - Aptamer-siRNA conjugates
KW - SiRNA
UR - http://www.scopus.com/inward/record.url?scp=84868352739&partnerID=8YFLogxK
U2 - 10.1038/mtna.2012.41
DO - 10.1038/mtna.2012.41
M3 - Article
AN - SCOPUS:84868352739
SN - 2162-2531
VL - 1
SP - e51
JO - Molecular Therapy - Nucleic Acids
JF - Molecular Therapy - Nucleic Acids
IS - 10
M1 - e51
ER -